Cardiomyocytes derived from human pluripotent stem cells for drug screening.
about
The adverse cardiac effects of Di(2-ethylhexyl)phthalate and Bisphenol ASupervised Machine Learning for Classification of the Electrophysiological Effects of Chronotropic Drugs on Human Induced Pluripotent Stem Cell-Derived CardiomyocytesHuman pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways.Complete restoration of multiple dystrophin isoforms in genetically corrected Duchenne muscular dystrophy patient-derived cardiomyocytes.iPSC technology--Powerful hand for disease modeling and therapeutic screenLabel-free imaging of metabolism and oxidative stress in human induced pluripotent stem cell-derived cardiomyocytesActivity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes.Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells.Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells.Inverting microwell array chip for the cultivation of human induced pluripotent stem cells with controlled aggregate size and geometrical arrangement.Current status of drug screening and disease modelling in human pluripotent stem cells.Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractilityOrgan-on-a-chip: development and clinical prospects toward toxicity assessment with an emphasis on bone marrow.High-throughput drug profiling with voltage- and calcium-sensitive fluorescent probes in human iPSC-derived cardiomyocytes.Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.Integrated platform for production and purification of human pluripotent stem cell-derived neural precursors.Phenotypic profiling of structural cardiotoxins in vitro reveals dependency on multiple mechanisms of toxicity.Automated detection and analysis of depolarization events in human cardiomyocytes using MaDEC.Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues.Cellular mechanisms for trazodone-induced cardiotoxicity.Variability of Action Potentials Within and Among Cardiac Cell Clusters Derived from Human Embryonic Stem CellsFunctional cardiomyocytes from human stem cells: a tool for determining the cardiotoxic potential of preclinical drugs.Structural Immaturity of Human iPSC-Derived Cardiomyocytes: In Silico Investigation of Effects on Function and Disease Modeling.
P2860
Q28396757-5174DFE4-EE0B-490D-96C0-3729E5DB0673Q28551775-AD9DABC7-34D3-4646-A765-1F71F73D3E6DQ30395748-5F6D9B67-743F-4CF5-96BC-54FB67003FBBQ30402943-0052FB03-2DAD-4CED-92B0-6B3018A9ABF4Q35194873-129E96A1-4A9E-481D-A009-1F99031DABCAQ36082427-398BC1AA-9D45-4374-8C3F-C68411CFBC10Q36912011-A1AFA399-EBB4-43ED-895A-062331414174Q37325576-B1FADDDD-50D0-4B2A-B539-BDE213D24DA2Q37542604-E31008FB-C75C-4B8D-A016-A9BF422A1DECQ37711224-9C6B0D71-FB15-422A-A2A6-5EBDF080E2F6Q37724485-4B3AE270-6F74-4991-9657-14F5B61BD90FQ38034129-CB9BF4F2-3002-4338-90A3-1375B07FDCE6Q38042792-1F1B391C-81BB-4DAB-8338-304CC2DAABE8Q38395139-40F1CA9A-1000-4A71-80CA-4806CCC23400Q38769738-60559F63-720E-45ED-9A73-D7AB2499EFC8Q38820849-487CE3CF-7C98-4F99-8447-B0A7293B9965Q38874111-2CA9EF64-378D-47CF-A618-CEB53E018C18Q39063845-D08AF9B2-8CC1-4D60-9131-4362A84F8808Q39211305-116282E2-F965-4E73-93A0-540284B04F11Q39696305-809C04DF-4C42-45E7-BDCF-5DFDE063DD52Q39812568-416FBE78-5DC8-482D-B4FF-50B50A3C0813Q40722531-96EF5409-513D-4992-9D2D-BF1BBC046C31Q42671611-8096D51C-F891-44ED-BA4B-28D8567F0EABQ43776247-13789BEB-3AF2-4C30-AC9E-B4E0BB37031CQ50219235-DBC776FD-0AAF-4C85-A60D-76643B64C741
P2860
Cardiomyocytes derived from human pluripotent stem cells for drug screening.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cardiomyocytes derived from human pluripotent stem cells for drug screening.
@en
Cardiomyocytes derived from human pluripotent stem cells for drug screening.
@nl
type
label
Cardiomyocytes derived from human pluripotent stem cells for drug screening.
@en
Cardiomyocytes derived from human pluripotent stem cells for drug screening.
@nl
prefLabel
Cardiomyocytes derived from human pluripotent stem cells for drug screening.
@en
Cardiomyocytes derived from human pluripotent stem cells for drug screening.
@nl
P2093
P1476
Cardiomyocytes derived from human pluripotent stem cells for drug screening.
@en
P2093
Joseph Itskovitz-Eldor
Naama Zeevi-Levin
Ofer Binah
P304
P356
10.1016/J.PHARMTHERA.2012.01.005
P577
2012-01-16T00:00:00Z